Home -> Law Blog Directory -> Corporate & Securities Law Blogs -> Antitrust Commentary
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Corporate & Securities Law
: Antitrust CommentaryD.C. Circuit Grants Rambus’ FTC Petition For Review
By Matthew S. Wild
Yesterday, the United States Court of Appeals for the D.C. Circuit granted Rambus’ petition for review. This decision was much awaited among antitrust counselors because it represented an attempt by the FTC to extend the antitrust laws to cover deceptive practices directed at standard-setting organizations. After administrative proceedings, the FTC held that Rambus violated Section 2 of the Sherman Act and Section 5 of the Federal Trade Commission Act by concealing to a standard-setting organization that it held patents in a technology which it urged the organization to adopt. Rambus then allegedly used the organization’s adoption of its technology to overcharge for licenses. In rejecting the claim under Section 2, the court explained, “if JEDEC, in the world that would have existed but for Rambus?s deception, would have standardized the very same technologies, Rambus?s alleged deception cannot be said to have had an effect on competition in violation of the antitrust laws; JEDEC?s loss of an opportunity to seek favorable licensing terms is not as such an antitrust harm. Yet the Commission did not reject this as being a possible?perhaps even the more probable?effect of Rambus?s conduct. We hold, therefore, that the Commission failed to demonstrate that Rambus?s conduct was exclusionary, and thus to establish its claim that Rambus unlawfully monopolized the relevant markets.” Rambus Inc. v. FTC, No. 07-1086 at 19 (D.C. Cir. Apr. 22, 2008). With respect to Section 5 of the FTCA, the court also expressed “serious concerns about strength of the evidence relied on to support some of the Commission?s crucial findings regarding the scope of JEDEC?s patent disclosure policies and Rambus?salleged violation of those policies.” Id. Notably, the court did not address whether such conduct would violate Section 5 even if it could not support liability under the Sherman Act. The FTC has recently taken such a position in its action against Negotiated Data in the March 10, 2008 Post. A copy of the slip opinion in Rambus is attached.
Full post as published by Antitrust Commentary on April 23, 2008 (boomark / email).
Specialty Lamp International
Recalls Counterfeit Circuit Breakers
FDA Issues Update on Safety Review Orlistat
Orlistat FDA Issues Update on Safety Review
Aurora Loan Faces Class Action over Mortgage Review Services
Aurora Loan Faces Class Action over Mortgage Review Services
FDA Review of Prostate Cancer Treatment Prompts Warning of Risk for Diabetes
Prostate Cancer Treatment FDA Review Prompts Warning of Risk for Diabetes
Xigris
Study Prompts FDA Safety Review
Lipitor
Review of Studies Show No Significant Benefit in Women

FTC Decision That Rambus Monopolized Reversed by D.C. Circuit Court
D.C. Circuit Overturns FTC Rambus Decision
Will the FTC Appeal the D.C. Circuits Decision in Rambus
Rambus Overturned by DC Circuit
Rambus Court: Price Raising Deception Not Competitive Harm








